Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1999

1.

Endoscopic ultrasound-guided pancreatic duct drainage.

Nakai Y, Kogure H, Isayama H, Koike K.

Saudi J Gastroenterol. 2019 Jan 10. doi: 10.4103/sjg.SJG_474_18. [Epub ahead of print] Review.

PMID:
30632484
2.

Intravesical treatment of chemotherapeutic agents sensitizes bacillus Calmette‑Guerin by the modulation of the tumor immune environment.

Hori S, Miyake M, Tatsumi Y, Morizawa Y, Nakai Y, Onishi S, Onishi K, Iida K, Gotoh D, Itami Y, Tanaka N, Fujimoto K.

Oncol Rep. 2019 Jan 10. doi: 10.3892/or.2019.6965. [Epub ahead of print]

PMID:
30628699
3.

Efficacy of an orally active small-molecule inhibitor of RANKL in bone metastasis.

Nakai Y, Okamoto K, Terashima A, Ehata S, Nishida J, Imamura T, Ono T, Takayanagi H.

Bone Res. 2019 Jan 3;7:1. doi: 10.1038/s41413-018-0036-5. eCollection 2019.

4.

Surrogate study endpoints in the era of cancer immunotherapy.

Hamada T, Kosumi K, Nakai Y, Koike K.

Ann Transl Med. 2018 Nov;6(Suppl 1):S27. doi: 10.21037/atm.2018.09.31. No abstract available.

5.

Preoperative predictive factors focused on inflammation-, nutrition-, and muscle-status in patients with upper urinary tract urothelial carcinoma undergoing nephroureterectomy.

Itami Y, Miyake M, Tatsumi Y, Gotoh D, Hori S, Morizawa Y, Iida K, Ohnishi K, Nakai Y, Inoue T, Anai S, Tanaka N, Shimada K, Hirao S, Fujimoto K.

Int J Clin Oncol. 2019 Jan 2. doi: 10.1007/s10147-018-01381-y. [Epub ahead of print]

PMID:
30604161
6.

Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma.

Miyake M, Owari T, Hori S, Nakai Y, Fujimoto K.

Res Rep Urol. 2018 Dec 14;10:251-261. doi: 10.2147/RRU.S173027. eCollection 2018. Review.

7.

Endoscopic papillary large balloon dilation without sphincterotomy for users of antithrombotic agents: a multicenter retrospective study.

Hakuta R, Kogure H, Nakai Y, Hamada T, Noguchi K, Saito K, Saito T, Takahara N, Mizuno S, Yagioka H, Ito Y, Tada M, Isayama H, Koike K.

Dig Endosc. 2018 Dec 26. doi: 10.1111/den.13326. [Epub ahead of print]

PMID:
30586206
8.

Quality of life in patients who underwent 125I brachytherapy, 125I brachytherapy combined with three-dimensional conformal radiation therapy, or intensity-modulated radiation therapy, for prostate cancer.

Nakai Y, Tanaka N, Asakawa I, Anai S, Miyake M, Hori S, Morizawa Y, Tatsumi Y, Hasegawa M, Fujii T, Fujimoto K.

J Radiat Res. 2018 Dec 20. doi: 10.1093/jrr/rry101. [Epub ahead of print]

PMID:
30576565
9.

The Gα12/13-coupled receptor LPA4 limits proper adipose tissue expansion and remodeling in diet-induced obesity.

Yanagida K, Igarashi H, Yasuda D, Kobayashi D, Ohto-Nakanishi T, Akahoshi N, Sekiba A, Toyoda T, Ishijima T, Nakai Y, Shojima N, Kubota N, Abe K, Kadowaki T, Ishii S, Shimizu T.

JCI Insight. 2018 Dec 20;3(24). pii: 97293. doi: 10.1172/jci.insight.97293. [Epub ahead of print]

10.

Dose-Dependent Increase of Nrf2 Target Gene Expression in Mice Exposed to Ionizing Radiation.

Miura S, Yamaguchi M, Yoshino H, Nakai Y, Kashiwakura I.

Radiat Res. 2018 Dec 19. doi: 10.1667/RR15203.1. [Epub ahead of print]

PMID:
30566388
11.

The delivery of mRNA to colon inflammatory lesions by lipid-nano-particles containing environmentally-sensitive lipid-like materials with oleic acid scaffolds.

Tanaka H, Watanabe A, Konishi M, Nakai Y, Yoshioka H, Ohkawara T, Takeda H, Harashima H, Akita H.

Heliyon. 2018 Dec 3;4(12):e00959. doi: 10.1016/j.heliyon.2018.e00959. eCollection 2018 Dec.

12.

Development of mild drug-induced sclerosing cholangitis after discontinuation of nivolumab.

Noda-Narita S, Mizuno S, Noguchi S, Watanabe K, Nakai Y, Koike K, Kage H, Nagase T.

Eur J Cancer. 2019 Jan;107:93-96. doi: 10.1016/j.ejca.2018.11.021. Epub 2018 Dec 13. No abstract available.

PMID:
30554074
13.

Changes in lower urinary tract symptoms after iodine-125 brachytherapy for prostate cancer.

Onishi K, Tanaka N, Miyake M, Nakai Y, Anai S, Torimoto K, Yamaki K, Asakawa I, Hasegawa M, Fujii T, Konishi N, Fujimoto K.

Clin Transl Radiat Oncol. 2018 Nov 17;14:51-58. doi: 10.1016/j.ctro.2018.11.001. eCollection 2019 Jan.

14.

[A Case of Rheumatoid Arthritis Developed during Treatment with Nivolumab for Renal Cell Carcinoma].

Tomizawa M, Nakai Y, Maesaka F, Owari T, Hara R, Miyake M, Inoue T, Anai S, Tanaka N, Fujimoto K.

Hinyokika Kiyo. 2018 Oct;64(10):397-401. doi: 10.14989/ActaUrolJap_64_10_397. Japanese.

PMID:
30543737
15.

Quantitative analysis of sensitivity to a Wnt3a gradient in determination of the pole-to-pole axis of mitotic cells by using a microfluidic device.

Hiraiwa T, Nakai Y, Yamada TG, Tanimoto R, Kimura H, Matsumoto Y, Miki N, Hiroi N, Funahashi A.

FEBS Open Bio. 2018 Nov 9;8(12):1920-1935. doi: 10.1002/2211-5463.12525. eCollection 2018 Dec.

16.

Successful salvage of allograft dysfunction triggered by transplant renal vein thrombosis immediately after kidney transplantation: a case report.

Hori S, Miyamoto T, Sakamoto K, Shimizu T, Ichikawa K, Morizawa Y, Gotoh D, Nakai Y, Miyake M, Yoneda T, Tanaka N, Yoshida K, Fujimoto K.

Int J Nephrol Renovasc Dis. 2018 Nov 23;11:321-327. doi: 10.2147/IJNRD.S185520. eCollection 2018.

17.

Comparison of early and delayed EUS-guided drainage of pancreatic fluid collection.

Chantarojanasiri T, Yamamoto N, Nakai Y, Saito T, Saito K, Hakuta R, Ishigaki K, Takeda T, Uchino R, Takahara N, Mizuno S, Kogure H, Matsubara S, Tada M, Isayama H, Koike K.

Endosc Int Open. 2018 Dec;6(12):E1398-E1405. doi: 10.1055/a-0751-2698. Epub 2018 Nov 23.

18.

Fluid sequestration is a useful parameter in the early identification of severe disease of acute pancreatitis.

Takeda T, Nakai Y, Mizuno S, Suzuki T, Sato T, Hakuta R, Ishigaki K, Saito K, Saito T, Watanabe T, Takahara N, Mouri D, Kogure H, Ito Y, Hirano K, Tada M, Isayama H, Koike K.

J Gastroenterol. 2018 Nov 26. doi: 10.1007/s00535-018-1531-6. [Epub ahead of print]

PMID:
30478723
19.

Endoscopic Ultrasound-Guided Biliary Drainage for Unresectable Hilar Malignant Biliary Obstruction.

Nakai Y, Kogure H, Isayama H, Koike K.

Clin Endosc. 2018 Nov 29. doi: 10.5946/ce.2018.094. [Epub ahead of print]

20.

[Standardization of Analysis Conditions and Prediction of Increase Prediction Using Blood Flow Analysis Software for Cerebral Aneurysms: Phantom Study and Clinical Study].

Nakai Y, Hamada H, Kittaka D, Noda C, Sato H, Kato K.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2018;74(11):1275-1285. doi: 10.6009/jjrt.2018_JSRT_74.11.1275. Japanese.

21.

Dual benefit of supplementary oral 5-aminolevulinic acid to pelvic radiotherapy in a syngenic prostate cancer model.

Miyake M, Tanaka N, Hori S, Ohnishi S, Takahashi H, Fujii T, Owari T, Ohnishi K, Iida K, Morizawa Y, Gotoh D, Itami Y, Nakai Y, Inoue T, Anai S, Torimoto K, Aoki K, Fujimoto K.

Prostate. 2018 Nov 18. doi: 10.1002/pros.23740. [Epub ahead of print]

PMID:
30450646
22.

Transient liver toxicity as a result of the oral administration of 5-aminolevulinic acid for photodynamic diagnosis in patients with bladder cancer.

Miyake M, Nakai Y, Hori S, Morizawa Y, Hirao Y, Fujimoto K.

Int J Urol. 2018 Nov 18. doi: 10.1111/iju.13856. [Epub ahead of print] No abstract available.

PMID:
30449052
23.

Assessment of Simultaneous Surgery for Odontogenic Sinusitis: Endoscopic Sinus Surgery With Endoscopic Apicoectomy.

Akiyama K, Nakai Y, Samukawa Y, Miyake M, Hoshikawa H.

J Craniofac Surg. 2019 Jan;30(1):239-243. doi: 10.1097/SCS.0000000000005134.

PMID:
30444772
24.

Quality of life worsened the most severely in patients immediately after intensity-modulated radiotherapy for prostate cancer.

Nakai Y, Tanaka N, Anai S, Miyake M, Asakawa I, Morizawa Y, Hori S, Torimoto K, Fujii T, Hasegawa M, Fujimoto K.

Res Rep Urol. 2018 Oct 23;10:169-180. doi: 10.2147/RRU.S168651. eCollection 2018.

25.

The Anti-Arthritis Effect of Olive-Derived Maslinic Acid in Mice is Due to its Promotion of Tissue Formation and its Anti-Inflammatory Effects.

Shimazu K, Fukumitsu S, Ishijima T, Toyoda T, Nakai Y, Abe K, Aida K, Okada S, Hino A.

Mol Nutr Food Res. 2018 Nov 8:e1800543. doi: 10.1002/mnfr.201800543. [Epub ahead of print]

PMID:
30411492
26.

A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer.

Saito K, Isayama H, Nakai Y, Takahara N, Ishigaki K, Takeda T, Hakuta R, Saito T, Uchino R, Kishikawa T, Hamada T, Mizuno S, Sasaki T, Kogure H, Matsubara S, Yamamoto N, Ijichi H, Tateishi K, Tada M, Koike K.

Invest New Drugs. 2018 Nov 9. doi: 10.1007/s10637-018-0691-9. [Epub ahead of print]

PMID:
30411217
27.

Placenta Specific 8 Suppresses IL-18 Production through Regulation of Autophagy and Is Associated with Adult Still Disease.

Segawa S, Kondo Y, Nakai Y, Iizuka A, Kaneko S, Yokosawa M, Furuyama K, Tsuboi H, Goto D, Matsumoto I, Sumida T.

J Immunol. 2018 Dec 15;201(12):3534-3545. doi: 10.4049/jimmunol.1800667. Epub 2018 Nov 7.

PMID:
30404814
28.

DNMTs and SETDB1 function as co-repressors in MAX-mediated repression of germ cell-related genes in mouse embryonic stem cells.

Tatsumi D, Hayashi Y, Endo M, Kobayashi H, Yoshioka T, Kiso K, Kanno S, Nakai Y, Maeda I, Mochizuki K, Tachibana M, Koseki H, Okuda A, Yasui A, Kono T, Matsui Y.

PLoS One. 2018 Nov 7;13(11):e0205969. doi: 10.1371/journal.pone.0205969. eCollection 2018.

29.

Instrumental evaluation sensitively detects subclinical skin changes by the epidermal growth factor receptor inhibitors and risk factors for severe acneiform eruption.

Kikuchi K, Nozawa K, Yamazaki N, Nakai Y, Higashiyama A, Asano M, Fujiwara Y, Kanda S, Ohe Y, Takashima A, Boku N, Inoue A, Takahashi M, Mori T, Taguchi O, Inoue Y, Mizutani H.

J Dermatol. 2019 Jan;46(1):18-25. doi: 10.1111/1346-8138.14691. Epub 2018 Nov 7.

PMID:
30402978
30.

Neural dynamics of verbal working memory in auditory description naming.

Kambara T, Brown EC, Silverstein BH, Nakai Y, Asano E.

Sci Rep. 2018 Oct 26;8(1):15868. doi: 10.1038/s41598-018-33776-2.

31.

Animal model of local tumor recurrence after resection using the murine MBT2 bladder cancer cell line in syngeneic C3H mice.

Miyake M, Hori S, Owari T, Morizawa Y, Nakai Y, Fujimoto K.

Int J Urol. 2018 Oct 16. doi: 10.1111/iju.13834. [Epub ahead of print] No abstract available.

PMID:
30324660
32.

Second-line chemotherapy in patients with advanced or recurrent biliary tract cancer: a single center, retrospective analysis of 294 cases.

Takahara N, Nakai Y, Isayama H, Sasaki T, Saito K, Oyama H, Kanai S, Suzuki T, Sato T, Hakuta R, Ishigaki K, Takeda T, Saito T, Mizuno S, Kogure H, Tada M, Koike K.

Invest New Drugs. 2018 Dec;36(6):1093-1102. doi: 10.1007/s10637-018-0670-1. Epub 2018 Oct 15.

PMID:
30324343
33.

A Ycf2-FtsHi Heteromeric AAA-ATPase Complex Is Required for Chloroplast Protein Import.

Kikuchi S, Asakura Y, Imai M, Nakahira Y, Kotani Y, Hashiguchi Y, Nakai Y, Takafuji K, Bédard J, Hirabayashi-Ishioka Y, Mori H, Shiina T, Nakai M.

Plant Cell. 2018 Nov;30(11):2677-2703. doi: 10.1105/tpc.18.00357. Epub 2018 Oct 11.

34.

Colony-stimulating factors detected in tumor cells and voided urine are potential prognostic markers for patients with muscle-invasive bladder cancer undergoing radical cystectomy.

Morizawa Y, Miyake M, Shimada K, Hori S, Tatsumi Y, Nakai Y, Tanaka N, Fujii T, Fujimoto K.

Res Rep Urol. 2018 Sep 21;10:103-111. doi: 10.2147/RRU.S166497. eCollection 2018.

35.

The outcomes of adrenalectomy for solitary adrenal metastasis: A 17-year single-center experience.

Hatano K, Horii S, Nakai Y, Nakayama M, Kakimoto KI, Nishimura K.

Asia Pac J Clin Oncol. 2018 Sep 30. doi: 10.1111/ajco.13078. [Epub ahead of print]

PMID:
30270570
36.

[Dissecting Internal Carotid Aneurysm Causing Epistaxis:A Case Report].

Kino H, Tsuruta W, Ito Y, Takigawa T, Shiigai M, Marushima A, Nakai Y, Yamamoto T, Matsumura A.

No Shinkei Geka. 2018 Sep;46(9):789-795. doi: 10.11477/mf.1436203815. Japanese.

PMID:
30262683
37.

Hepatic fatty acid biosynthesis in KK-Ay mice is modulated by administration of persimmon peel extract: A DNA microarray study.

Izuchi R, Ishijima T, Okada S, Abe K, Nakai Y.

Food Sci Nutr. 2018 Jul 20;6(6):1657-1663. doi: 10.1002/fsn3.728. eCollection 2018 Sep.

38.

Approved Anti-cancer Drugs Target Oncogenic Non-coding RNAs.

Velagapudi SP, Costales MG, Vummidi BR, Nakai Y, Angelbello AJ, Tran T, Haniff HS, Matsumoto Y, Wang ZF, Chatterjee AK, Childs-Disney JL, Disney MD.

Cell Chem Biol. 2018 Sep 20;25(9):1086-1094.e7. doi: 10.1016/j.chembiol.2018.05.015. Epub 2018 Jun 28.

PMID:
30251629
39.

NACC1, as a Target of MicroRNA-331-3p, Regulates Cell Proliferation in Urothelial Carcinoma Cells.

Morita K, Fujii T, Itami H, Uchiyama T, Nakai T, Hatakeyama K, Sugimoto A, Miyake M, Nakai Y, Tanaka N, Shimada K, Yamazaki M, Fujimoto K, Ohbayashi C.

Cancers (Basel). 2018 Sep 21;10(10). pii: E347. doi: 10.3390/cancers10100347.

40.

Microwave treatment of the cornea leads to localised disruption of the extracellular matrix.

Morgan SR, Hieda O, Nakai Y, Boote C, Hayes S, Kinoshita S, Meek KM, Quantock AJ.

Sci Rep. 2018 Sep 13;8(1):13742. doi: 10.1038/s41598-018-32110-0.

41.

Correlation of Immune Cells and Cytokines in the Tumor Microenvironment with Elevated Neutrophil-To-Lymphocyte Ratio in Blood: An Analysis of Muscle-Invasive Bladder Cancer.

Morizawa Y, Miyake M, Shimada K, Hori S, Tatsumi Y, Nakai Y, Onishi S, Tanaka N, Konishi N, Fujimoto K.

Cancer Invest. 2018;36(7):395-405. doi: 10.1080/07357907.2018.1506800. Epub 2018 Sep 10.

PMID:
30199269
42.

[A case of relapsed hemosuccus pancreaticus successfully treated with interventional radiology].

Nakamura T, Ikeda A, Itokawa Y, Kusumoto K, Nakai Y, Azechi H, Fujii S, Kusaka T, Kokuryu H.

Nihon Shokakibyo Gakkai Zasshi. 2018;115(9):825-832. doi: 10.11405/nisshoshi.115.825. Japanese.

PMID:
30197397
43.

DNA-loaded nano-adjuvant formed with a vitamin E-scaffold intracellular environmentally-responsive lipid-like material for cancer immunotherapy.

Kawai M, Nakamura T, Miura N, Maeta M, Tanaka H, Ueda K, Higashi K, Moribe K, Tange K, Nakai Y, Yoshioka H, Harashima H, Akita H.

Nanomedicine. 2018 Nov;14(8):2587-2597. doi: 10.1016/j.nano.2018.08.006. Epub 2018 Aug 29.

PMID:
30170077
44.

Prospective multicenter study of primary EUS-guided choledochoduodenostomy using a covered metal stent.

Nakai Y, Isayama H, Kawakami H, Ishiwatari H, Kitano M, Ito Y, Yasuda I, Kato H, Matsubara S, Irisawa A, Itoi T.

Endosc Ultrasound. 2018 Aug 27. doi: 10.4103/eus.eus_17_18. [Epub ahead of print]

45.

Aortic Dissection and Cardiac Dysfunction Emerged Coincidentally During the Long-Term Treatment with Angiogenesis Inhibitors for Metastatic Renal Cell Carcinoma.

Takada M, Yasui T, Oka T, Shioyama W, Kuroda T, Nakai Y, Nishimura K, Mukai M, Fujita M.

Int Heart J. 2018 Sep 26;59(5):1174-1179. doi: 10.1536/ihj.17-461. Epub 2018 Aug 29.

46.

Isocitrate dehydrogenase 1 mutation sensitizes intrahepatic cholangiocarcinoma to the BET inhibitor JQ1.

Fujiwara H, Tateishi K, Kato H, Nakatsuka T, Yamamoto K, Tanaka Y, Ijichi H, Takahara N, Mizuno S, Kogure H, Matsubara S, Nakai Y, Koike K.

Cancer Sci. 2018 Nov;109(11):3602-3610. doi: 10.1111/cas.13784. Epub 2018 Sep 17.

47.

High-sensitivity sulfur isotopic measurements for Antarctic ice core analyses.

Takahashi K, Nakai Y, Motizuki Y, Ino T, Ito S, Ohkubo SB, Minami T, Takaku Y, Yamaguchi Y, Tanaka M, Motoyama H.

Rapid Commun Mass Spectrom. 2018 Dec 15;32(23):1991-1998. doi: 10.1002/rcm.8275.

PMID:
30153343
48.

Early pancreatic stent placement in wire-guided biliary cannulation: A multicenter retrospective study.

Hakuta R, Hamada T, Nakai Y, Isayama H, Kogure H, Takahara N, Mizuno S, Yagioka H, Togawa O, Matsubara S, Ito Y, Yamamoto N, Tada M, Koike K.

J Gastroenterol Hepatol. 2018 Aug 27. doi: 10.1111/jgh.14453. [Epub ahead of print]

PMID:
30152138
49.
50.

Phase-amplitude coupling between interictal high-frequency activity and slow waves in epilepsy surgery.

Motoi H, Miyakoshi M, Abel TJ, Jeong JW, Nakai Y, Sugiura A, Luat AF, Agarwal R, Sood S, Asano E.

Epilepsia. 2018 Oct;59(10):1954-1965. doi: 10.1111/epi.14544. Epub 2018 Aug 26.

PMID:
30146766

Supplemental Content

Support Center